Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
PennantPark Floating Rate Capital Ltd., a NYSE-listed business development company focused on middle-market U.S. private companies, announced it will release its third fiscal quarter 2026 results after market close on August 10, 2026, followed by a conference call on August 11, 2026 to discuss financial results. The company primarily invests in flo…
Kalaris Therapeutics appointed Laurie Keating, an accomplished biopharmaceutical executive with extensive legal and operational expertise, to its Board of Directors effective August 1, 2026. Laurie Keating's addition comes as Kalaris advances its clinical-stage treatment TH103 for retinal diseases. The company also announced the departure of Morana…
Navitas Semiconductor announced it will release its financial results for the second quarter of 2026 on July 27 after market close. The company's CEO and CFO will host an earnings call to discuss results and outlook. Navitas specializes in next-gen GaN and SiC semiconductor technologies for AI data centers, energy infrastructure, and industrial app…
Longeveron Inc. announced the appointment of Marie Washburn as Senior Vice President and Chief Financial Officer, effective July 13, 2026. Ms. Washburn brings over 20 years of experience in pharmaceutical and biotech finance leadership. This leadership transition occurs as Longeveron anticipates top-line Phase 2b clinical trial results for its lead…
Organogenesis Holdings Inc. announced that the FDA has accepted for review its Biologics License Application for ReNu®, a biologic therapy aimed at treating pain in symptomatic knee osteoarthritis. The FDA set a target action date of April 24, 2027. ReNu® is poised to become the first non-surgical biologic treatment for knee OA, a condition affecti…
Aligos Therapeutics announced it has received a $25 million upfront payment from an exclusive license agreement with Xiamen Amoytop Biotech for pevifoscorvir sodium in Greater China. The drug has also been granted Breakthrough Therapy Designation by China's regulatory authorities, potentially expediting its approval for treating chronic hepatitis B…
PennantPark Investment Corporation (NYSE: PNNT), a business development company focused on U.S. middle-market private companies, will release its financial results for the third fiscal quarter ended June 30, 2026 on August 10, 2026, after market close. The company will host a conference call on August 11 to discuss the results, inviting all interes…
Encore Capital Group, a specialty finance company focused on consumer debt recovery, announced it will release its second quarter 2026 financial results on August 5, 2026. The company will host a conference call and webcast for investors on the same day to discuss the results.
Elicio Therapeutics has successfully closed a $15 million registered direct offering led by new institutional investors to fund its clinical programs, primarily focusing on the Phase 1 development of ELI-002 7P for metastatic pancreatic ductal adenocarcinoma (PDAC). The company plans to leverage the proceeds to advance its immunotherapy pipeline ta…
Abivax SA, a clinical-stage biotech company listed on Nasdaq and Euronext Paris, announced the closing of its public offering raising approximately $920 million gross. The net proceeds of about $874 million will finance its operations until late 2029, supporting advancement of its lead drug candidate in Phase 3 trials for ulcerative colitis and oth…
Control Empresarial de Capitales S.A. de C.V., a major shareholder linked to the Slim Family, executed a divestment of 200,000 Class A Common Shares in PBF Energy Inc. (NYSE:PBF) on July 1, 2026. The transaction, valued at $9,388,660, occurred as PBF Energy trades near its 52-week high, reflecting complex dynamics in the refining sector. This sale …
Hershey Trust Co., a major ten percent owner of The Hershey Co. (NASDAQ:HSY), executed a sale of 10,000 common shares on July 2, 2026, totaling approximately $1.8 million. Despite the divestiture, the Trust retains significant exposure through direct common holdings, indirect shares via the Milton Hershey School Trust, and a substantial block of co…
Russell E. Schuster III, Chief Commercial Officer at AdaptHealth Corp. (NASDAQ:AHCO), executed a sale of company stock on July 1, 2026. The transaction, valued at $117,711, involves the disposition of 11,275 shares. This sale was carried out automatically under a pre-existing Rule 10b5-1 trading plan established by Mr. Schuster on March 2, 2026. Fo…
Meta’s announcement that it will commercialize excess AI infrastructure as Meta Compute sent shares through a volatile week. The market punished the stock on capex concerns; I see the move as an overreaction. Meta still prints strong ad growth, generates $48.3B in free cash flow, and trades at ~21x earnings with a $1.52T market cap. This is a mediu…
MidCap Financial Investment Corporation is set to announce its financial results for the quarter ended June 30, 2026, with a conference call scheduled for August 6, 2026. The company is an externally managed BDC focused on middle-market senior secured loans and other debt and equity investments, aiming to generate current income and some capital ap…
Bulgargaz and BOTAŞ have signed a protocol that suspends the existing terms of a long-term gas contract for 15 months. During that interval, Bulgaria will pay only for the import capacity it uses under improved terms, and the two firms will work on renegotiating the contract to reflect current market conditions. The agreement follows talks between …
Globavend Holdings Limited announced the expiration of all outstanding Series A Warrants, simplifying its capital structure and removing a source of potential shareholder dilution. The Company is advancing its dual-business model by growing its established cross-border e-commerce logistics operations and accelerating its AI-driven digital entertain…
21shares announced a 1-for-10 reverse share split for its 21Shares 2x Long Sui ETF (Ticker: TXXS), effective July 6, 2026. The reverse split reduces the number of outstanding shares by approximately 90%, increasing the per-share NAV and market price proportionally without affecting the total investment value for shareholders. The move is structural…
The official death toll from the June 24 earthquakes that struck Caracas and nearby coastal areas has risen to 3,535, officials said on Monday. Authorities report 16,740 injured and 17,854 people without housing more than a week after the twin quakes, which registered magnitudes of 7.2 and 7.5 and occurred within seconds of each other. The disaster…
Jensen Huang's recent push against bespoke ASICs has exposed Nvidia to renewed competitive, pricing and regulatory risk. We are downgrading the stock and proposing a mid-term short: entry at $680.00, target $520.00, stop loss $760.00. The trade targets a re-rating driven by demand shifts, ASP pressure and coalition-driven customer negotiation.
Howard Horn, Chief Financial Officer of Ultragenyx Pharmaceutical Inc., executed a transaction on July 1, 2026, selling 4,698 shares of common stock valued at $155,644. The sale, conducted under a Rule 10b5-1 trading plan, leaves Horn with a direct holding of 100,991 shares, a figure that encompasses Restricted Stock Units subject to vesting schedu…
Kylian Mbappe strongly rebuked Paraguayan senator Celeste Amarilla after she posted a racist tirade on X following Paraguay's exit from the World Cup. Mbappe's penalty secured a 1-0 victory for France in Philadelphia. The French Football Federation said it will report the matter to the public prosecutor's office and pursue criminal proceedings.
VivoPower PLC announced progress on a feasibility study for integrating a battery energy storage system (BESS) at its Mo i Rana data center in Norway. The BESS aims to unlock participation in multiple Nordic grid reserve markets, targeting incremental annualized EBITDA of up to $4 million. The investment also supports enhanced power quality and res…
Allegro is a niche leader in sensor and high-voltage power ICs that stands to benefit from a shift to 800-VDC architectures across EVs, robotics and industrial systems. Strong top-line execution, healthy free cash flow and improving leadership bench make a buyable setup after recent consolidation. The trade below balances upside toward the 52-week …
Shares of Space Exploration Technologies Corp fell after an early intraday advance as traders reduced exposure ahead of two key events scheduled for July 7: the company’s formal entry into the Nasdaq-100 index and the expiration of the 25-calendar-day IPO underwriter quiet period. The quiet period lift is expected to prompt analyst initiations from…
